MA H1178

Bill

MA H1178

Relative to promoting transparency in the pharmaceutical industry

Introduced
01/22/2019

In Committee
01/22/2019

Crossed Over

Passed

Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

For legislation to promote transparency in the pharmaceutical industry and to establish a prescription drug academic detailing program to enhance the health of residents of the Commonwealth. Health Care Financing.

AI Summary

This bill aims to promote transparency in the pharmaceutical industry. Key provisions include: 1. Defining key terms like "pharmaceutical manufacturing company," "pharmacy benefit manager," and "pipeline drugs." 2. Expanding the role of the Health Policy Commission to analyze pharmaceutical and pharmacy benefit manager data, such as cost trends, rebates, and the impact of drugs in development. 3. Establishing a prescription drug academic detailing program to provide evidence-based information to prescribers and dispensers about the therapeutic and cost-effective use of prescription drugs. 4. Requiring pharmaceutical companies to provide early notice and data about pipeline drugs and biosimilars that may have a significant impact on state healthcare spending. 5. Enhancing the attorney general's ability to monitor trends in the healthcare market, including prescription drug costs and price increases. 6. Requiring pharmacists to notify consumers if the pharmacy retail price for a prescription is less than the consumer's cost-sharing amount under their health plan. The overall goal is to increase transparency around pharmaceutical pricing and utilization in order to improve healthcare outcomes and reduce unnecessary costs for the Commonwealth.

Committee Categories

Health and Social Services

Sponsors (1)

Ron Mariano (D),

Last Action

Reporting date extended to Thursday December 31, 2020, pending concurrence (on 06/22/2020)

Official Document

https://malegislature.gov/Bills/191/H1178

(13 Companion Bills)

Version:

Document Type	Source Location	Created
State Bill Page	https://malegislature.gov/Bills/191/H1178	02/27/2019
Bill	https://malegislature.gov/Bills/191/H1178.pdf	02/27/2019

Bill	Bill Name	Last Action	Type
H253	Establishing fuel price transparency	Accompanied a study order, see H5043	Similar To
H2627	Relative to film tax credit transparency	Accompanied a study order, see H5080	Similar To
H2768	Providing for sustainability and transparency standards by Massachusetts business entities	Accompanied a study order, see H5103	Similar To
H2827	Relative to transparency in private utility construction contracts	Bill reported favorably by committee and referred to the committee on House Ways and Means	Similar To
H4012	Relative to children’s health and wellness	Reported by H4210	Similar To
H4017	Relative to hospital access to discounted prescription drug prices	Signed by the Governor, Chapter 82 of the Acts of 2019	Similar To
H4210	Relative to children’s health and wellness	Signed by the Governor, Chapter 124 of the Acts of 2019	Similar To
S1677	To increase transparency of taxpayers rights	Accompanied a study order, see S2549	Similar To
S2289	Relative to public safety and transparency by transportation network companies	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To
S2295	To increase consumer transparency about insurance provider networks	Accompanied H913	Similar To
S2397	Relative to pharmaceutical access, costs and transparency	Reprinted as amended, see S2409	Similar To
S2409	Relative to pharmaceutical access, costs and transparency	Read; and referred to the committee on House Ways and Means	Similar To
S960	To increase transparency in the Massachusetts land record systems to protect the property rights of homeowners and businesses	Accompanied H1413	Similar To

Bill > H1178

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (1)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary